Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$59K of HALO shares in the open market
Traded Dec 1, 2025 · Filed Dec 2, 2025
- ~$59K
- Reported value · 829 sh @ $71.60
- 42K
- Holds after · shares reported
- +59.0%
- stock since the trade · S&P 500 +13.9%, $68.10 → $108.31 on Oct 5
Why it stands out
A board member of Halozyme sold $59K of Halozyme shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Dec 1, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Dec 2, 2025
Director$25K–$100KPre-arranged plan referenced
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$59,356
Shares × reported transaction price
- Timing vs results
28 days after results of Nov 3, 2025, 58 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results